|
Catheter-based coronary interventions: stents
Citations 371-380 of 991 total displayed.
|
Past content
(since Jan 1999):
|
- Interventional Cardiology
Four-Year Angiographic and Intravascular Ultrasound Follow-Up of Patients Treated With Sirolimus-Eluting Stents
- J. Eduardo Sousa, Marco A. Costa, Alexandre Abizaid, Fausto Feres, Ana C. Seixas, Luiz F. Tanajura, Luiz A. Mattos, Robert Falotico, Judith Jaeger, Jeffrey J. Popma, Patrick W. Serruys, and Amanda G.M.R. Sousa
Circulation 2005;111:2326-2329; published online before print as doi:10.1161/01.CIR.0000164271.01172.1A
[Abstract]
[Full text]
- Articles
Randomized Comparison of a Titanium-Nitride-Oxide-Coated Stent With a Stainless Steel Stent for Coronary Revascularization. The TiNOX Trial
- Stephan Windecker, Rüdiger Simon, Markus Lins, Volker Klauss, Franz R. Eberli, Marco Roffi, Giovanni Pedrazzini, Tiziano Moccetti, Peter Wenaweser, Mario Togni, David Tüller, Rainer Zbinden, Christian Seiler, Julinda Mehilli, Adnan Kastrati, Bernhard Meier, and Otto M. Hess
Circulation published May 9, 2005, doi:10.1161/CIRCULATIONAHA.104.486647
[Abstract]
- Articles
Effect of Difficulty Affording Health Care on Health Status After Coronary Revascularization
- John Spertus, Carole Decker, Catherine Woodman, John House, Phil Jones, James O’Keefe, and A. Michael Borkon
Circulation published May 9, 2005, doi:10.1161/CIRCULATIONAHA.104.474775
[Abstract]
- Basic Science for Clinicians
Molecular Basis of Restenosis and Drug-Eluting Stents
- Marco A. Costa and Daniel I. Simon
Circulation 2005;111:2257-2273, doi:10.1161/01.CIR.0000163587.36485.A7
[Full text]
- Correspondence
Letter Regarding Article by McKechnie et al, "Prognostic Implication of Anemia on In-Hospital Outcomes After Percutaneous Coronary Intervention" • Response
- Holger Reinecke, Günter Breithardt, Mauro Moscucci, Ronald McKechnie, Dean Smith, Eva Kline-Rogers, David Share, Cecelia Montoye, Michael J. O’Donnell, Anthony C. DeFranco, William L. Meengs, Richard McNamara, John G. McGinnity, Kirit Patel, Arthur Riba, and Sanjaya Khanal
Circulation 2005;111:e263-264e, doi:10.1161/01.CIR.0000162464.51816.D3
[Full text]
- Correspondence
Letter Regarding Article by Sawhney et al, "Treatment of Left Anterior Descending Coronary Artery Disease With Sirolimus-Eluting Stents" • Response
- Derk J. Drenth, Felix Zijlstra, Piet W. Boonstra, Neil Sawhney, Paul S. Teirstein, Jeffrey W. Moses, Martin B. Leon, Richard E. Kuntz, Jeffrey J. Popma, William Bachinsky, Theodore Bass, Samuel DeMaio, Edward Fry, and David R. Holmes, Jr
Circulation 2005;111:e265-266e, doi:10.1161/01.CIR.0000162512.06704.36
[Full text]
- Interventional Cardiology
Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention: Results From the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Study
- Giuseppe Patti, Giuseppe Colonna, Vincenzo Pasceri, Leonardo Lassandro Pepe, Antonio Montinaro, and Germano Di Sciascio
Circulation 2005;111:2099-2106; published online before print as doi:10.1161/01.CIR.0000161383.06692.D4
[Abstract]
[Full text]
- Interventional Cardiology
Effectiveness and Safety of Sirolimus-Eluting Stents in the Treatment of Restenosis After Coronary Stent Placement
- Franz-Josef Neumann, Walter Desmet, Eberhard Grube, Johannes Brachmann, Patrizia Presbitero, Paolo Rubartelli, Andreas Mügge, Francesco Di Pede, Diana Füllgraf, Wim Aengevaeren, Leonardo Spedicato, and Jeffrey J. Popma
Circulation 2005;111:2107-2111, doi:10.1161/01.CIR.0000162467.53001.6B
[Abstract]
[Full text]
- Articles
Four-Year Angiographic and Intravascular Ultrasound Follow-Up of Patients Treated With Sirolimus-Eluting Stents
- J. Eduardo Sousa, Marco A. Costa, Alexandre Abizaid, Fausto Feres, Ana C. Seixas, Luiz F. Tanajura, Luiz A. Mattos, Robert Falotico, Judith Jaeger, Jeffrey J. Popma, Patrick W. Serruys, and Amanda G.M.R. Sousa
Circulation published April 25, 2005, doi:10.1161/01.CIR.0000164271.01172.1A
[Abstract]
- Correspondence
Letter Regarding Article by Hlatky et al, "Medical Costs and Quality of Life 10 to 12 Years After Randomization to Angioplasty or Bypass Surgery for Multivessel Coronary Artery Disease" • Response
- Faizel Osman, Sohail Qaisar, Michael Pitt, Mark A. Hlatky, Derek B. Boothroyd, Kathryn A. Melsop, Maria M. Brooks, Daniel B. Mark, Bertram Pitt, Guy S. Reeder, William J. Rogers, Thomas J. Ryan, Patrick L. Whitlow, and Robert D. Wiens
Circulation 2005;111:e176-177e, doi:10.1161/01.CIR.0000160371.73867.2E
[Full text]
|
|
